{
    "2021-07-14": [
        [
            {
                "time": "2023-10-16",
                "original_text": "Best Psychedelic Stocks to Buy Now",
                "features": {
                    "keywords": [
                        "Psychedelic",
                        "Stocks",
                        "Buy",
                        "Now"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "The Zacks Analyst Blog Highlights: JPMorgan, Goldman Sachs, Microsoft, AbbVie, and Enbridge",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "JPMorgan",
                        "Goldman Sachs",
                        "Microsoft",
                        "AbbVie",
                        "Enbridge"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-16",
                "original_text": "Morning Bell With Jim Cramer: Boeing and AbbVie",
                "features": {
                    "keywords": [
                        "Morning Bell",
                        "Jim Cramer",
                        "Boeing",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "aerospace",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}